A Vaccine Study for High Risk Cancers
Stopped unexpectedly low screening results leading to poor accrual
Conditions
- Neuroblastoma
- Rhabdomyosarcoma
- Osteogenic Sarcoma
Interventions
- BIOLOGICAL: MAGE-A1, MAGE-A3, and NY-ESO-1 Vaccine
Sponsor
Penn State University